Michael R. Reich – författare

THE FOUNDATIONAL WORK IN HEALTH REFORM, CELEBRATING 15 YEARS OF INFLUENCEFeaturing a new introduction by the authorsGetting Health Reform Right is the world's leading text for understanding and managing health systems and their reform. Its simple, analytical model allows readers to design their own approach to improve health-system performance based on three outcomes of greatest importance (health status, citizen satisfaction, and financial risk protection), with step-by-step instructions for defining problems, diagnosing causes, devising solutions, and implementing changes. "Rapidly assumed the status of a classic and proved an inspiration to a generation of students and policymakers. It is as relevant today as when it was first published." -Peter C. Smith, Emeritus Professor of Health Policy, Imperial College Business School, London"Has become the mainstay of health-system reform conversations among policymakers in India. Its unique and accessible framing, which goes beyond abstract ideas, has resonated strongly in debates over how to improve health system performance." -Nachiket Mor, former Director, Bill and Melinda Gates Foundation, India

Pivotal to Asia's future will be the robustness of its medical universities. Lessons learned in the past and the challenges facing these schools in the future are outlined in this collection, which offers valuable insights for other medical education systems as well. The populations in these rapidly growing countries rely on healthcare systems that can vigorously respond to the concerns of shifting demographics, disease, and epidemics. The collected works focus on the education of physicians and health professionals, policy debates, cooperative efforts, and medical education reform movements.

Pivotal to Asia's future will be the robustness of its medical universities. Lessons learned in the past and the challenges facing these schools in the future are outlined in this collection, which offers valuable insights for other medical education systems as well. The populations in these rapidly growing countries rely on healthcare systems that can vigorously respond to the concerns of shifting demographics, disease, and epidemics. The collected works focus on the education of physicians and health professionals, policy debates, cooperative efforts, and medical education reform movements.

Many people in developing countries lack access to health technologies, even basic ones. Why do these problems in access persist? What can be done to improve access to good health technologies, especially for poor people in poor countries?This book answers those questions by developing a comprehensive analytical framework for access and examining six case studies to explain why some health technologies achieved more access than others. The technologies include praziquantel (for the treatment of schistosomiasis), hepatitis B vaccine, malaria rapid diagnostic tests, vaccine vial monitors for temperature exposure, the Norplant implant contraceptive, and female condoms.Based on research studies commissioned by the Bill & Melinda Gates Foundation to better understand the development, adoption, and uptake of health technologies in poor countries, the book concludes with specific lessons on strategies to improve access. These lessons will be of keen interest to students of health and development, public health professionals, and health technology developers—all who seek to improve access to health technologies in poor countries.

This book applies an established analytical framework for health sector reform (Getting Health Reform Right, Oxford, 2004) to the performance problems of the pharmaceutical sector. The book is divided into three sections. The first section presents the basic ideas for analysis. It begins by insisting that reform start with a clear understanding of the performance deficiencies of the current system. Like all priority setting in the public sector, this 'definition of the problem' involves both ethical choices and political processes. Early chapters explain the foundations of these ideas and apply them to the pharmaceutical sector. The relationship of ultimate outcomes (like health status or risk protection) to classic health systems concepts like efficiency, access and quality is also explored. The last chapter in the first part is devoted to 'diagnosis' - explaining how to move from the definition of a problem to an understanding of how the functioning of the system produces the undesirable outcomes in question.The second part of the book devotes one chapter to each of five 'control knobs': finance, payment, organization, regulation and persuasion. These are sets of potential interventions that governments can use to improve pharmaceutical sector performance. Each chapter presents basic concepts and discusses examples of reform options. Throughout we provide 'conditional guidance' - avoiding the approach of a 'one size fits all' model of 'best practices' in these five arenas for reform. Instead we stress the need for local knowledge of political systems, administrative capacities, community values and market conditions in order to design pharmaceutical sector policies appropriate to a country’s particular circumstances.The last part of the book is a set of teaching cases. Each is preceded by questions and is followed by a brief note on the lessons to be learned. The goal is to help readers develop the skills they need to deal effectively with pharmaceutical sector reform problems in their own countries.

Distinguished international experts evaluate in this volume how health and nutrition in poor countries have been affected by economic adjustments made in response to external shocks. They explore the origins, magnitude, and future outlook of the adjustments required of developing countries; discuss the impact on health and nutritional services; consider what policies would be most effective in minimizing the adverse effects on food and nutrition; and examine what can be done to achieve the best possible health services in the face of economic constraints and crisis.

La couverture sanitaire universelle pour un développement durable inclusif synthétise les expériences de 11 pays ? Bangladesh, Brésil, Éthiopie, France, Ghana, Indonésie, Japon, Pérou, Thaïlande, Turquie et Vietnam - dans la mise en ?uvre de politiques et de stratégies d'atteinte et de maintien de la CSU.

Los fines de la cobertura universal de salud son asegurar que toda la poblacion pueda acceder a servicios de salud de calidad. Parses que han logrado la cobertura universal de salud estan demostrando c6mo estos programas pueden servir como mecanismos esenciales de mejora de la salud.